Clicky

Evelo Biosciences, Inc.(EVLO)

Description: Evelo Biosciences Inc operates as a bio-technology company. The firm develops therapies for the treatment of the gut-body network. Evelo Biosciences also offers treatment for cancer and inflammatory diseases.


Keywords: Cancer Inflammatory Diseases Bio Technology Treatment For Cancer Ym Biosciences

Home Page: www.evelobio.com

EVLO Technical Analysis

620 Memorial Drive
Cambridge, MA 02139
United States
Phone: 617 577 0300


Officers

Name Title
Dr. Balkrishan Gill Ph.D. Pres, CEO & Director
Dr. Jonathan B. Zung Ph.D. Chief Devel. Officer
Ms. Marella Thorell CFO & Treasurer
Mr. Stephen J. Carriere VP & Chief Accounting Officer
Dr. Chun Zhang Ph.D. Chief Technical Operations & Quality Officer
Dr. Mark Bodmer Ph.D. Chief Scientific Officer and Pres of R&D
Ms. Kendra Sweeney Head of Investor Relations & Capital Markets
Ms. Jessica Cotrone VP & Head of Communications
Ms. Leslie Wardwell-Scott Ph.D. VP and Head of Corp. Devel. & Strategic Integration
Ms. Julie Carretero Chief People Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 22.3128
Price-to-Sales TTM: 0
IPO Date: 2018-05-09
Fiscal Year End: December
Full Time Employees: 122
Back to stocks